Replies to post #500329 on Anavex Life Sciences Corp (AVXL)

[boi568]

FDA guidelines for early AD (relating to ADL), as far as we know, have not changed. Draft guidance does not replace a prior final guidance.

I do think the FDA will not let a guidance get in the way of an approval in the new pilot program since I view that new approach as somewhat politicized.